Nanomedicines and Biomedical Engineering

Organisational unit: Research Group

Organisation Profile

Our research team makes the unique bridge between medical engineering, pharmaceutical nanotechnology and biomedical research by combining unique techniques, such as microfluidic glass technology, to help to build innovative nanomedicines/nanovectors and multidrug loading. To design and test the functionality and efficacy of these nanomedicines, we use state-of-the-art nanotheranostic technologies for personalized medicine, which allow the precisely engineering of materials at nanoscale to develop novel therapeutic formulations, including industrial scale-up validation, batch-to-batch reproducibility, and controllability of the nanomaterials’ physicochemical properties for translation into the clinic.

Latest research outputs

  1. Process optimization of ecological probe sonication technique for production of rifampicin loaded niosomes

    Research output: Contribution to journalArticleScientificpeer-review

  2. Accepted/In press

    Photothermal Responsive Nanosized Hybrid Polymersome as Versatile Therapeutics Co-Delivery Nanovehicle for Effective Tumor Suppression

    Research output: Contribution to journalReview ArticleScientificpeer-review

ID: 14619009